Renfu Pharmaceutical (600079.SH): Carbidopa-Levodopa oral solution obtained drug registration certificate.

China Fortune Financial APP News, Renfu Medicine (600079.SH) issued an announcement. The company's controlling subsidiary, Yichang Renfu Pharmaceutical Co., Ltd. (referred to as "Yichang Renfu", in which the company holds 80% of its shares), recently received the "Drug Registration Certificate" for carbossatex oral solution issued by the National Medical Products Administration.